Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis - Wikidata - wikimedia - TriplyDB

Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis

Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis

http://www.wikidata.org/entity/Q35271053

about

Candida infections and their prevention.Self-adjuvanting glycopeptide conjugate vaccine against disseminated candidiasis.Diagnostic value of immunoglobulin G antibodies against Candida enolase and fructose-bisphosphate aldolase for candidemia.Oral Immunization Against Candidiasis Using Lactobacillus casei Displaying Enolase 1 from Candida albicans Adaptive immunity to fungi.Vaccines in the treatment of invasive candidiasis.New approaches in the development of a vaccine for mucosal candidiasis: progress and challenges Recent progress in vaccines against fungal diseases Active immunizations with peptide-DC vaccines and passive transfer with antibodies protect neutropenic mice against disseminated candidiasis Fungal cell wall vaccines: an update.Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases.Universal fungal vaccines: could there be light at the end of the tunnel?Immune modulators as adjuncts for the prevention and treatment of invasive fungal infections.Immunological basis of anti-Candida vaccines focused on synthetically prepared cell wall mannan-derived manno-oligomers.Adjuvants and delivery systems for antifungal vaccines: current state and future developments.The protective role of immunoglobulins in fungal infections and inflammation.Immunotherapy of Fungal Infections.Immunization with Pneumocystis Cross-Reactive Antigen 1 (Pca1) Protects Mice against Pneumocystis Pneumonia and Generates Antibody to Pneumocystis jirovecii.Candida albicans-derived mannoproteins activate NF-κB in reporter cells expressing TLR4, MD2 and CD14.Oral Vaccine Development by Molecular Display Methods Using Microbial Cells.The evaluation of β-(1 → 3)-nonaglucoside as an anti-Candida albicans immune response inducer.Human Anti-Als3p Antibodies Are Surrogate Markers of NDV-3A Vaccine Efficacy Against Recurrent Vulvovaginal Candidiasis.Molecular and Physiological Study of by Quantitative Proteome Analysis Candida albicans: Clinical Relevance, Pathogenesis, and Host Immunity

P2860

Q33775256-408204DE-AC02-4B11-977D-776CDA518567 Q34259665-900C38AA-74CC-4B79-985C-D32BB4850D25 Q34750701-ACC5E18E-5C5A-4A13-92C8-D6BD9FDD7C1C Q35052906-D27ADC1D-D616-46F2-B3F0-6951D1DA76EC Q35164257-08333E8B-0234-4E03-A9D8-92CE8560464D Q36147010-2235F721-AE24-44A6-AFF0-80151E979731 Q36158337-048ED6BC-8B72-46CF-899F-66E0CDD967AC Q36179629-B7D964FD-7B88-46C4-A0BB-3515DA366F06 Q36421907-02EDBDBE-E663-4908-AC67-5B4B68D036AF Q36525342-199C2696-AC4B-4B09-A44A-D9C7388B5184 Q38011299-12AD0A72-6B9E-42FC-AA36-14BC43D7D680 Q38038044-6192FA92-0B2A-46C9-B9CA-DD109185FEE2 Q38067451-9C3A08E3-C078-4D4E-BA1A-93F8208720FD Q38243016-DCB4E895-BBB0-40C2-8440-D16537F9A1D1 Q38264288-09BAF50D-52B9-41B9-B20C-D7E298D66996 Q38268922-B12102F1-38BB-4440-8C21-7C15BEB3B74F Q38635409-A69403F8-E5CA-4A67-B280-734C8514CCC0 Q40392438-A02ED71F-CE57-4A0F-BAED-30CA5A247086 Q47242917-BD3439A5-3342-4914-AD41-60A5504B802E Q51372211-1B58CE65-9A07-4C3F-A54B-D5577B3E15AE Q51699904-02DB51F8-A4DE-4104-BC51-EF0BBFA180C7 Q55396489-6DD845F4-B0D6-428B-8BFD-1398A52EA6ED Q58723623-E4343C93-2007-41C8-B238-084D25CB323D Q59282466-21A5AADF-36CC-46AE-99BB-5622B8DC656E

P2860

Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis

http://www.wikidata.org/entity/Q35271053

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis

@ast

Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis

@en

type

label

Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis

@ast

Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis

@en

prefLabel

Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis

@ast

Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis

@en

P1433

Q35271053-24791DBA-3179-44EA-96C3-242394813795

P1476

Q35271053-61979E37-0D44-414B-B09A-EC2C0AE7A1FF

P2093

Q35271053-6761EA8B-5FB0-4CFA-BE3E-465588FDEB4B

Q35271053-825B4094-DF90-4410-AA71-8E0EC7D04261

P2860

Q35271053-052172FE-8D34-4576-AFFD-8BDC1E7A3357

Q35271053-1CA79956-090E-466D-A47E-4CD3F65590A7

Q35271053-1F1A821B-0D19-4701-AC5E-CAE12F8CBB4A

Q35271053-230A97A5-B998-4145-894B-57909B53A453

Q35271053-26DE7245-BFD8-4FB8-AD19-C843EFD9A855

Q35271053-2921CB8E-74B8-4C05-84D6-4A7E10F60C0A

Q35271053-2A497F99-87CE-4D87-803B-B1593B80B46D

Q35271053-36A1EEF7-6831-45F2-A08C-8282E653E990

Q35271053-3D90B42A-D711-415D-AFAE-70BAEDAB9C8C

Q35271053-41FDEC71-AF61-444D-842F-5A008C51E5DB

P304

Q35271053-5266F3E3-5B18-4064-8335-6B732BC0C9A5

P31

Q35271053-7FE0E983-C1E3-43A3-A2D0-60E2B60013FA

P356

Q35271053-AA8289F7-BF6B-4C9C-9DF6-564118F2687C

P433

Q35271053-7E70C9DD-36A3-4309-850A-2E5A83470331

P478

Q35271053-0E14DD82-F41B-440E-AE6C-2E39055C6ED5

P577

Q35271053-A8DF9D80-FD24-4D20-9932-9BC6B2F1B34E

P698

Q35271053-CFB7285E-15BF-4AA0-8D85-96AA5DEA0EBA

P921

Q35271053-91AA95BF-2FD1-4F4B-A7E8-7FBA21AEDA87

P932

Q35271053-5754AC53-08B0-4F53-8F19-9676CE9CD374

P356

P1433

Clinical and Vaccine Immunology

P1476

Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis

@en

P2093

Hong Xin

http://www.w3.org/2001/XMLSchema#string

Jim E Cutler

http://www.w3.org/2001/XMLSchema#string

P2860

Fructose-bisphosphate aldolases: an evolutionary history

Prophylactic vaccination with phage-displayed epitope of C. albicans elicits protective immune responses against systemic candidiasis in C57BL/6 mice.

Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherence

Proteomics-based identification of novel Candida albicans antigens for diagnosis of systemic candidiasis in patients with underlying hematological malignancies.

Fungicidal monoclonal antibody C7 binds to Candida albicans Als3.

Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.

A vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection.

Protection against candidiasis by an immunoglobulin G3 (IgG3) monoclonal antibody specific for the same mannotriose as an IgM protective antibody.

Epidemiology of Candida species infections in critically ill non-immunosuppressed patients.

Hybridoma passage in vitro may result in reduced ability of antimannan antibody to protect against disseminated candidiasis

P304

1656-1667

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/CVI.05215-11

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21832099

http://www.w3.org/2001/XMLSchema#string

P921

P932

3187024

http://www.w3.org/2001/XMLSchema#string